Cargando…

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Maneu, Victoria, Lax, Pedro, Cuenca, Nicolás
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451557/ https://www.ncbi.nlm.nih.gov/pubmed/34100441 http://dx.doi.org/10.4103/1673-5374.314305

Ejemplares similares

Systemic inflammation induced by lipopolysaccharide aggravates inherited retinal dystrophy
por: Noailles, Agustina, et al.
Publicado: (2018)

Photosensitive Melanopsin-Containing Retinal Ganglion Cells in Health and Disease: Implications for Circadian Rhythms
por: Lax, Pedro, et al.
Publicado: (2019)

Persistent inflammatory state after photoreceptor loss in an animal model of retinal degeneration
por: Noailles, Agustina, et al.
Publicado: (2016)

Natural Compounds from Saffron and Bear Bile Prevent Vision Loss and Retinal Degeneration
por: Fernández-Sánchez, Laura, et al.
Publicado: (2015)

Current and Future Treatment of Retinitis Pigmentosa
por: Cross, Nancy, et al.
Publicado: (2022)

Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications
por: Pinilla, Isabel, et al.
Publicado: (2022)

Gradual Increase in Environmental Light Intensity Induces Oxidative Stress and Inflammation and Accelerates Retinal Neurodegeneration
por: Kutsyr, Oksana, et al.
Publicado: (2020)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Adenosine triphosphate maintenance by branched chain amino acids as a novel neuroprotective strategy for retinal neurodegenerative diseases
por: Hasegawa, Tomoko, et al.
Publicado: (2019)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Cellular and molecular alterations in neurons and glial cells in inherited retinal degeneration
por: Martínez-Gil, Natalia, et al.
Publicado: (2022)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Current controversies in glia-to-neuron conversion therapy in neurodegenerative diseases
por: Cao, Peng, et al.
Publicado: (2023)

Chronic lung disease, lung regeneration and future therapeutic strategies
por: Cao, Xuan-Ye, et al.
Publicado: (2018)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

Purinergic Receptors P2X7 and P2X4 as Markers of Disease Progression in the rd10 Mouse Model of Inherited Retinal Dystrophy
por: Martínez-Gil, Natalia, et al.
Publicado: (2022)

Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases
por: Hellmers, Natalie, et al.
Publicado: (2016)

Complement pathway in Alzheimer’s pathology and retinal neurodegenerative disorders – the road ahead
por: Mirzaei, Mehdi, et al.
Publicado: (2019)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseases
por: Klein, Antonia N., et al.
Publicado: (2018)

Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats
por: Fernández-Sánchez, Laura, et al.
Publicado: (2017)

Oxidative Stress as a Main Contributor of Retinal Degenerative Diseases
por: Pinilla, Isabel, et al.
Publicado: (2022)

Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models
por: Fernandez, Caridad Ivette, et al.
Publicado: (2017)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs
por: Cross, Nancy, et al.
Publicado: (2022)

Potential therapeutic interventions based on the role of the endoplasmic reticulum stress response in progressive neurodegenerative diseases
por: Puri, Basant K., et al.
Publicado: (2018)

Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives
por: Silveira, Gustavo de Bem, et al.
Publicado: (2021)

Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa
por: Fernández-Sánchez, Laura, et al.
Publicado: (2018)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Blood exosomes as a tool for monitoring treatment efficacy and progression of neurodegenerative diseases
por: Abdel-Haq, Hanin
Publicado: (2019)

Astrocytes and Müller Cell Alterations During Retinal Degeneration in a Transgenic Rat Model of Retinitis Pigmentosa
por: Fernández-Sánchez, Laura, et al.
Publicado: (2015)

The Absence of Toll-Like Receptor 4 Mildly Affects the Structure and Function in the Adult Mouse Retina
por: Noailles, Agustina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nojr7vda2udfm9fpgoud5utl6d